Download FREE Report Sample
Download Free sampleGene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
Gene Delivery System Market contains market size and forecasts of Gene Delivery System in Global, including the following market information:
Global Gene Delivery System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Gene Delivery System market was valued at 7282.5 million in 2021 and is projected to reach US$ 37570 million by 2028, at a CAGR of 26.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viral Gene Delivery System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gene Delivery System include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and bluebird bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Gene Delivery System companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Delivery System Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Gene Delivery System Market Segment Percentages, by Type, 2021 (%)
Viral Gene Delivery System
Non-viral Gene Delivery System
Global Gene Delivery System Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Gene Delivery System Market Segment Percentages, by Application, 2021 (%)
Neurological Diseases
Cancer
Others
Global Gene Delivery System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Gene Delivery System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Delivery System revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Gene Delivery System revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
